Used in research for neurodegenerative disorders, particularly Parkinson’s disease, due to its ability to selectively inhibit monoamine oxidase B (MAO-B). This inhibition helps increase dopamine levels in the brain, which may support neuronal function and slow disease progression. It is also explored for potential cognitive enhancement and neuroprotective effects in preclinical studies. Commonly applied in cellular and animal models to evaluate behavioral and biochemical outcomes related to dopamine metabolism and oxidative stress.